Chest Shielding in Premature Infants During Phototherapy

Completed · Not applicable

Conditions studied: Patent Ductus Arteriosus in Premature Infants

In brief

This is a feasibility study where Infants will be randomized to either chest shielding with aluminum foil or chest shielding without aluminum foil while undergoing phototherapy for premature infants. The primary outcome is patent ductus arteriosus.

Key facts

Study ID

NCT02552927

Run by

University of Rochester

People needed

50

Starts

2015-08-01

Expected to finish

2019-02-13

Last updated by the study team

2020-09-18

Who can join

Age: 0 and older, up to 1. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• less or equal to 29 weeks or 1000g at birth
• Admitted to the NICU (Neonatal intensive care unit) within 24 hours after birth
• English speaking parents

You may not qualify if…

• Congenital abnormalities
• Chromosomal disorders
• Cyanotic heart defects
• Nitric oxide
• Prophylactic phototherapy
• Unlikely to survive beyond 72 hours according to the attending neonatologist
• Do not require phototherapy

Where it is running

• University of Rochester — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.